Member Info for Resistance1

I defer to your knowledge on this one. Just biding my time awaiting the evitable reversal in this share's fortune

Nutmeg I not sure if the (very low) level of shorting is institution driven -- although I appreciate in the past this has been the case. Too small to bother. More likely the result of 'pound shop' PI shorters. There is a poster on this board and on another forum that fits this bill -- blatant scaremongering posts full of nonsense. In a period of low volume and poor sentiment, brought on my the conflict, it doesn't take much to shift the SP.

I note on the RNS it is the first time that the long-standing Government department has been identified as the Defence department. Clearly the current situation will result in vastly increased expenditure for defence, with cyber security pivotal to this. I would expect more rapid announcements in the coming weeks as security is beefed up.

Looks like the US state for the 5-year Edgility contract was California some research reveals. So when we say only one State at the moment, that State has an economy larger than the whole of the UK. See below:

BEVERLY HILLS, Calif., January 31, 2023 (GLOBE NEWSWIRE) - Next Generation Advanced (NGA), a global leader in NG911 digital emergency communications services and source for complete, adaptable, and reliable solutions announced today that they were awarded the $37M contract to provide the 9-8-8 call-handling system for the State of California.

Edgility supplied by BATM's US based division Telco Systems. Treated as an indigenous supplier by US authorities. 911 service suppliers deliver their services a across many states in the US. Wrong again Dartron.

Stuart there also wasn't a value on the previous 911 contract either. However this new long term contract is a big positive and can be rolled out in another 49 states. So these 911 deals will probably come thick and fast.

Nutmeg if there are any deals in the pipeline the coming week will be the time to announce them. In this instance you are correct.

Staggering tone deaf response from Dartron. Unpleasant in the extreme. Already the most unpopular poster, he then tries to gloat over short-term SP falls resulting from the horrific situation developing Israel. He then tries to backtrack claiming he wasn't fully aware of the news. Pathetic. I hope we wont see the likes of him again. Just incase... now filtered

Nutmeg. You seem to be enjoying doing a bit of ambulance chasing after recent events. Suggest you keep your current internal battle to whether you are buying in or not to yourself.

Realdeal. For your information he is currently in a neutral stance waiting to buy back in. He was recently in 'full ramp mode' when holding shares and prior to that a massive detractor.

This agreement was posted on BATM's social streams, so hopefully they are involved in some way

Flatcap. I don't know if I'm considered a stalwart, but for what's worth I actually bought more on the recent 'spike.' Not a great deal but some to average down some more. Of course if I did it now I would be even better placed. I don't trade this share I am investing for the long-term. I have seen many opportunities to actively trade for 10-15% gains in BATM but with my luck I would probably sell just on a sustained upward trajectory....

Thanks TW. A very similar company to BATM's cyber division is the UK company PQshield. They have turnover of $8.3m a year and are valued at $120m. They are developing quantum products as well and supply defence/Governments. This reiterates the immense value of the various BATM divisions.

Thanks Nutmeg. There certainly seems to be renewed interest in the share. New faces on this board and generally excitement about BATM's prospects in general. Many of us have be patient and hopefully well rewarded for being so.

Break-up Value

So my calculations are based on the achieved sale values of companies of the same (divisional) scale and stage of development that operate in each of BATM’s divisional areas. Each of BATM's divisions could realise the following sale price:

Cyber $100m

Medical waste $25m

Edgility (current scale) $250m

Networking (Remaining Telco) $100m

Medical distribution $50m

Ador/Adaltis (BATM stake) $125m

Total $650m (This is 5 x current share price)

About right?

Yes it would seem he got more intel out of Moti on what was coming down the track compared with the narrative/guidance than came with the H1 results

MDxlab in the CMD presentation, page 9 of the Med/diagnostics section it says it is a near term product pipeline. It is based on the Nucleic acid detection system. Used on location in hospitals to diagnose and array of syndromes like respiratory, hepatitis and genetic disorders. Market like my post of a few days ago for NatLab is huge a fast growing. Need JV partner to rapidly gain market traction

Hi Happy, you can't complain that BATM are building marketing departments to exploit their IP. Especially in the US. What are they to do, sit on the IP and keep it locked away? If they didn't ramp up their spending on this I would be very worried.

In April this year Oxford Nanopore Technologies plc (LSE: ONT) announced that they have teamed up with bioMérieux to bring nanopore sequencing to the infectious disease diagnostics market. They say their solution will be commercially available in approx. 24-months (April 2025.) The molecular diagnostics market will reach £24.9bn by this time. This is roughly the same timeline for full commercial availability for Ador Natlab molecular diagnostics platform for infectious diseases. Interesting Oxford Nanopore is currently valued at £2bn on (stripping out covid testing) sales of around £160m and is yet to break even. It was worth at the end of 2021 nearly £6bn and will probably get back to those heady heights when true stock valuations return. Ador Natlab will be the market leader in terms of processing speed, diagnosis cost and the number of different diseases it detects. In June’s CMD presentation it was flagged a JV partner would be brought on board to rapidly commercialise it. Down the line, Ador Natlab would also be further developed to test the gut microbiome for traces of other diseases and for oncology diagnosis. Overall, I had no idea of the scale of opportunity that awaits us here. I appreciate for some posters, this wont be good enough.

Either the 'wronged ex-investors' that negatively post here are driven by being wholly publicly spirited with an abundance of time on their hands or (more likely) they have placed small shorts on the stock.